Multicentric plasma cell variant of Castleman's disease with cutaneous involvement

被引:21
作者
Klein, WM
Rencic, A
Munshi, NC
Nousari, CH
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Dermatol, Baltimore, MD 21205 USA
[3] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Univ Penn Hlth Syst, Dept Dermatol, Philadelphia, PA USA
关键词
D O I
10.1111/j.0303-6987.2004.00117.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Castleman's disease (CD) is a rare low-grade B-cell lymphoproliferative disorder that can be associated with a variety of antibody-mediated paraneoplastic syndromes. The disease is classified clinically by two forms and three histologic variants. Methods: We describe the clinical and pathological features of a 44-year-old woman who presented with an autoimmune hemolytic anemia, thrombocytosis, polyclonal gammopathy, axillary lymphadenopathy, hepatosplenomegaly, and several erythematous and violaceous nodules and plaques without scaling involving the trunk and extremities. Results: Histologic examination of the skin lesions revealed a deep dermal and subcutaneous nodular mononuclear infiltrate composed primarily of polyclonal plasmacytoid cells without atypia and an increased vascular proliferation. Additional studies including a bone marrow and lymph node biopsy, serum and urine protein electrophoresis, and computed tomography scans supported the diagnosis of multicentric plasma cell variant of CD with an associated autoimmune paraneoplastic hemolytic anemia. Conclusion: Cutaneous involvement in CD is part of the multicentric nature and should be considered in the differential diagnosis of a polyclonal plasma cell-rich lymphoproliferative disorder associated with paraneoplastic autoimmune disease.
引用
收藏
页码:448 / 452
页数:5
相关论文
共 20 条
  • [1] Cutaneous immunocytoma presenting with multiple infiltrated macules and papules
    Aberer, E
    Cerroni, L
    Kerl, H
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (02) : 324 - 329
  • [2] ANHALT GJ, 1997, ADV DERMATOL, V12, P7
  • [3] CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
  • [4] 2-4
  • [5] A SYSTEMIC LYMPHOPROLIFERATIVE DISORDER WITH MORPHOLOGIC FEATURES OF CASTLEMANS DISEASE - CLINICAL FINDINGS AND CLINICOPATHOLOGIC CORRELATIONS IN 15 PATIENTS
    FRIZZERA, G
    PETERSON, BA
    BAYRD, ED
    GOLDMAN, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) : 1202 - 1216
  • [6] Primary cutaneous plasmacytoma:: a clinicopathological study of two cases with a long-term follow-up and review of the literature
    Kazakov, DV
    Belousova, IE
    Müller, B
    Palmedo, G
    Samtsov, AV
    Burg, G
    Kempf, W
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2002, 29 (04) : 244 - 248
  • [7] KELLER AR, 1972, CANCER-AM CANCER SOC, V29, P670, DOI 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO
  • [8] 2-#
  • [9] SKIN INVOLVEMENT IN GIANT LYMPH-NODE HYPERPLASIA (CASTLEMANS DISEASE)
    KUBOTA, Y
    NOTO, S
    TAKAKUWA, T
    TADOKORO, M
    MIZOGUCHI, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (05) : 778 - 780
  • [10] LEGERRAVET MB, 1991, BLOOD, V78, P2923